| For: | Carreño V, Bartolomé J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol 2012; 18(23): 2887-2894 [PMID: 22736911 DOI: 10.3748/wjg.v18.i23.2887] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i23/2887.htm |
| Number | Citing Articles |
| 1 |
Hossein Keyvani, Farah Bokharaei-Salim, Seyed Hamidreza Monavari, Maryam Esghaei, Mohssen Nassiri Toosi, Shahin Fakhim, Zohreh-Azita Sagigh, Seyed Moayed Alavian. Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis. Hepatitis Monthly 2013; 13(8) doi: 10.5812/hepatmon.11290
|
| 2 |
Donatien Serge Mbaga, Sebastien Kenmoe, Jacky Njiki Bikoï, Guy Roussel Takuissu, Marie Amougou-Atsama, Etienne Atenguena Okobalemba, Jean Thierry Ebogo-Belobo, Arnol Bowo-Ngandji, Martin Gael Oyono, Jeannette Nina Magoudjou-Pekam, Ginette Irma Kame-Ngasse, Alex Durand Nka, Alfloditte Flore Feudjio, Cromwel Zemnou-Tepap, Elie Adamou Velhima, Juliette Laure Ndzie Ondigui, Rachel Audrey Nayang-Mundo, Sabine Aimee Touangnou-Chamda, Yrene Kamtchueng Takeu, Jean Bosco Taya-Fokou, Chris Andre Mbongue Mikangue, Raoul Kenfack-Momo, Cyprien Kengne-Ndé, Carole Stephanie Sake, Seraphine Nkie Esemu, Richard Njouom, Lucy Ndip, Sara Honorine Riwom Essama. Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis. World Journal of Methodology 2022; 12(3): 179-190 doi: 10.5662/wjm.v12.i3.179
|
| 3 |
Ming-Ling Chang, Wei-Ting Chen, Li-Heng Pao, Cheng-Hsun Chiu, Rong-Nan Chien, Saumitra Das. HCV Ab titer and ALT level indicate occult hepatitis C virus infection in treatment-naive HCV Ab-positive and HCV Ab-negative patients: a 3-year prospective cohort study. Microbiology Spectrum 2025; 13(8) doi: 10.1128/spectrum.02922-24
|
| 4 |
Hossein Keyvani, Mehdi Fazlalipour, Seyed Hamid Reza Monavari, Hamid Reza Mollaie. Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine Development. Asian Pacific Journal of Cancer Prevention 2012; 13(12) doi: 10.7314/APJCP.2012.13.12.5917
|
| 5 |
Philip Kiely. Screening blood donors for hepatitis C virus: the challenge to consider cost‐effectiveness. Transfusion 2015; 55(6) doi: 10.1111/trf.13127
|
| 6 |
Naiema K. Ali, Ragaa R. Mohamed, Bothina E. Saleh, Manal M. Alkady, Eman S. Farag. Occult hepatitis C virus infection among haemodialysis patients. Arab Journal of Gastroenterology 2018; 19(3) doi: 10.1016/j.ajg.2018.09.001
|
| 7 |
Maryam Sheikh, Farah Bokharaei-Salim, Seyed Hamidreza Monavari, Angila Ataei-Pirkooh, Maryam Esghaei, Najmeh Moradi, Roghayeh Babaei, Atousa Fakhim, Hossein Keyvani. Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users. Archives of Virology 2019; 164(2) doi: 10.1007/s00705-018-4066-5
|
| 8 |
Robério Amorim de Almeida Pondé. Detection of anti-HCV antibodies in the clinical classification and epidemiological surveillance of HCV infection. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10827-2
|
| 9 |
Justyna Kaźmierczak, Agnieszka Pawełczyk, Kamila Caraballo Cortes, Marek Radkowski. Seronegative Hepatitis C Virus Infection. Archivum Immunologiae et Therapiae Experimentalis 2014; 62(2) doi: 10.1007/s00005-013-0257-7
|
| 10 |
Alshymaa Hassnine, Zeinab Saad. Rome IV Diagnostic Criteria for Functional Gastrointestinal Disorders in Patients with Chronic Hepatitis C Virus. Middle East Journal of Digestive Diseases 2022; 14(2) doi: 10.34172/mejdd.2022.275
|
| 11 |
Yong-Song Guan, Qing He. Role of antiviral therapy in the management of hepatocellular carcinoma. Anti-Cancer Drugs 2013; 24(4) doi: 10.1097/CAD.0b013e32835ec39a
|
| 12 |
Mohammad Saeid Rezaee-Zavareh, Behzad Einollahi. Treatment of Occult Hepatitis C Virus Infection: Does It Need Special Attention?. Hepatitis Monthly 2014; 14(6) doi: 10.5812/hepatmon.16665
|
| 13 |
N. G. Yaroslavtseva, D. S. Tikhomirov, L. I. Nikolaeva, A. V. Dedova, E. N. Ovchinnikova, O. N. Misko, T. Yu. Romanova, P. I. Makhnovskiy, A. E. Grishechkin, T. A. Tupoleva. LOW CONCENTRATIONS OF HEPATITIS C VIRUS RNA IN SEROLOGICALLY MILD INFECTION. Problems of Virology 2019; 64(1) doi: 10.18821/0507-4088-2019-64-1-30-35
|
| 14 |
Tamara Vasilevna Antonova, M. S. Nozhkin, D. A. Lioznov. Chronic Hepatitis С and Oncohematological Diseases. Clinical Oncohematology 2024; 16(1) doi: 10.21320/2500-2139-2023-16-1-46-53
|
| 15 |
Mohammad Reza Hedayati-Moghaddam, Hossein Soltanian, Sanaz Ahmadi-Ghezeldasht. Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries: A systematic review and meta-analysis. World Journal of Hepatology 2021; 13(2): 242-260 doi: 10.4254/wjh.v13.i2.242
|
| 16 |
Mohammad Saeid Rezaee‐Zavareh, Mahdi Ramezani‐Binabaj, Seyed Moayed Alavian. Screening for occult hepatitis C virus infection: Does it need special attention?. Hepatology 2015; 62(1) doi: 10.1002/hep.27626
|
| 17 |
Maeesa Wadood, Muhammad Usman. Comparative Analysis of Electrochemiluminescence Assay and Chemiluminescent Microparticle Immunoassay for the Screening of Hepatitis C. Indian Journal of Hematology and Blood Transfusion 2019; 35(1) doi: 10.1007/s12288-018-0968-3
|
| 18 |
Banafsheh Hasanvand, Habibollah Mirzaei, Babak Hadian, parsa sasaei, Sara Garavand, Hemanta Adhikary, Sayyad Khanizadeh. Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran. VirusDisease 2024; 35(3) doi: 10.1007/s13337-024-00881-y
|
| 19 |
Mehdi Fazlalipour, Hossein Keyvani, Seyed Hamid Reza Monavari, Hamid Reza Mollaie. Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris. Jundishapur Journal of Microbiology 2015; 8(4) doi: 10.5812/jjm.8(4)2015.17157
|
| 20 |
Elnaz Agi, Saber Asghari, Ali Namvar, Niloofar Khairkhah, Niloofar Naderi, Ali Anvar, Alireza Azizi Saraji, Azam Bolhassani. Molecular Study of Occult Hepatitis C Infection among Iranian Hemophilia Patients Treated with Direct-acting Antiviral Agents. Journal of Medical Microbiology and Infectious Diseases 2020; 8(1) doi: 10.29252/JoMMID.8.1.1
|
| 21 |
Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239
|
| 22 |
Jessica M. Dale, Simon P. Hood, Ori Bowen, Helen Bright, Keith L. Cutler, Neil Berry, Neil Almond, Robert Goldin, Peter Karayiannis, Nicola J. Rose. Development of hepatic pathology in GBV‐B‐infected red‐bellied tamarins (Saguinus labiatus). Journal of Medical Virology 2020; 92(12) doi: 10.1002/jmv.25769
|
| 23 |
Xu Wang, Song Wang, Zhen-Hua Liu, Wen-Qian Qi, Qian Zhang, Yong-Gui Zhang, De-Rong Sun, Yan Xu, Hong-Guang Wang, Zhong-Xie Li, Xian-Ling Cong, Ping Zhao, Chang-Yu Zhou, Jiang-Bin Wang. Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection. World Journal of Gastroenterology 2018; 24(20): 2191-2202 doi: 10.3748/wjg.v24.i20.2191
|
| 24 |
Hong Lin, Xian Chen, Shaowen Zhu, Ping Mao, Shanshan Zhu, Yanchun Liu, Chengyin Huang, Jun Sun, Jin Zhu. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China. Intervirology 2016; 59(4) doi: 10.1159/000455854
|
| 25 |
Eliane Silva, Sara Marques, Hugo Osorio, Bernardo Canhao, Joao Madaleno, Adelia Simao, Armando Carvalho. Occult hepatitis C infection: viruses with infectious potential in Huh7.5 and MDBK cell lines suggest HCV/OCI transmission. Pharmacy & Pharmacology International Journal 2023; 11(1) doi: 10.15406/ppij.2023.11.00394
|
| 26 |
Robério Amorim de Almeida Pondé. Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection. European Journal of Clinical Microbiology & Infectious Diseases 2013; 32(8) doi: 10.1007/s10096-013-1857-1
|
| 27 |
Sogol Jamshidi, Farah Bokharaei‐Salim, Maryam Esghaei, Mohammad‐Navid Bastani, Saba Garshasbi, Sara Chavoshpour, Farzaneh Dehghani‐Dehej, Shahin Fakhim, Khadijeh Khanaliha. Occult HCV and occult HBV coinfection in Iranian human immunodeficiency virus‐infected individuals. Journal of Medical Virology 2020; 92(12) doi: 10.1002/jmv.25808
|
| 28 |
M. C. Roque Cuéllar, J. R. García‐Lozano, B. Sánchez, J. M. Praena‐Fernández, C. Martínez Sierra, A. Núñez‐Roldán, J. Aguilar‐Reina. Lymphomagenesis‐related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection. Journal of Viral Hepatitis 2016; 23(8) doi: 10.1111/jvh.12526
|
| 29 |
Soha S. Abdelrahim, Rasha Khairy, Mona Abdel-Monem Esmail, Mahmoud Ragab, Mohamed Abdel-Hamid, Sayed F. Abdelwahab. Occult hepatitis C virus infection among Egyptian hemodialysis patients. Journal of Medical Virology 2016; 88(8) doi: 10.1002/jmv.24467
|
| 30 |
S Zaltron, A Spinetti, L Biasi, C Baiguera, F Castelli. Chronic HCV infection: epidemiological and clinical relevance. BMC Infectious Diseases 2012; 12(S2) doi: 10.1186/1471-2334-12-S2-S2
|
| 31 |
Arwa Kamhawy, Zeinab Nabil Ahmed Said, Salwa Elsayed Abdelhamid, Mohammad El-Sayed, Rasha Eletreby, Hasan El Garem, Mohamed El Kassas, Gamal Esmat. Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals. Arab Journal of Gastroenterology 2021; 22(2) doi: 10.1016/j.ajg.2021.03.001
|
| 32 |
María de la Luz Martínez-Rodríguez, Luis A. Uribe-Noguez, Carla I. Arroyo-Anduiza, José Antonio Mata-Marin, Gamaliel Benitez-Arvizu, María L. Portillo-López, Alicia Ocaña-Mondragón, Yury E Khudyakov. Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City. PLOS ONE 2018; 13(10) doi: 10.1371/journal.pone.0205659
|
| 33 |
Renata P.C. Barros, Luciana Scotti, Marcus T. Scotti. Exploring Secondary Metabolites Database of Apocynaceae, Menispermaceae, and Annonaceae to Select Potential Anti-HCV Compounds. Current Topics in Medicinal Chemistry 2019; 19(11) doi: 10.2174/1568026619666190510094228
|
| 34 |
Ahmad Ayadi, Amir Hossein Nafari, Fatemeh Sakhaee, Kimia Rajabi, Yaser Ghaderi, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Host genetic factors and clinical parameters influencing the occult hepatitis C virus infection in patients on chronic hemodialysis: Is it still a controversial infection?. Hepatology Research 2019; 49(6) doi: 10.1111/hepr.13325
|
| 35 |
María C. Roque‐Cuéllar, Berta Sánchez, José R. García‐Lozano, Juan M. Praena‐Fernández, José L. Márquez‐Galán, Antonio Núñez‐Roldán, José Aguilar‐Reina. Hepatitis C virus‐specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells. Liver International 2014; 34(6) doi: 10.1111/liv.12320
|
| 36 |
Ghada Abdelmoemen, Samy Abdelkader Khodeir, Sabry Abou- Saif, Abdelrahman Kobtan, Sherief Abd-Elsalam. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study. Environmental Science and Pollution Research 2018; 25(6) doi: 10.1007/s11356-017-0897-y
|
| 37 |
Juliette Laure Ndzie Ondigui, Sebastien Kenmoe, Cyprien Kengne-Ndé, Jean Thierry Ebogo-Belobo, Guy Roussel Takuissu, Raoul Kenfack-Momo, Donatien Serge Mbaga, Serges Tchatchouang, Josiane Kenfack-Zanguim, Robertine Lontuo Fogang, Elisabeth Zeuko'o Menkem, Ginette Irma Kame-Ngasse, Jeannette Nina Magoudjou-Pekam, Arnol Bowo-Ngandji, Nadège Mafopa Goumkwa, Seraphine Nkie Esemu, Lucy Ndip, Sara Honorine Riwom Essama, Judith Torimiro. Epidemiology of occult hepatitis B and C in Africa: A systematic review and meta-analysis. Journal of Infection and Public Health 2022; 15(12) doi: 10.1016/j.jiph.2022.11.008
|
| 38 |
Brenda Y. Hernandez, Xuemei Zhu, Sandi Kwee, Owen T.M. Chan, Naoky Tsai, Gordon Okimoto, David Horio, Katherine A. McGlynn, Sean Altekruse, Linda L. Wong. Viral Hepatitis Markers in Liver Tissue in Relation to Serostatus in Hepatocellular Carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(11) doi: 10.1158/1055-9965.EPI-13-0397
|
| 39 |
Ghada Fahmy Helaly, Amel Gaber Elsheredy, Adel Abd El Basset Mousa, Hayat Khalifa Fadlalla Ahmed, Abd El-Gaffar Sabry Oluyemi. Seronegative and occult hepatitis C virus infections in patients with hematological disorders. Archives of Virology 2017; 162(1) doi: 10.1007/s00705-016-3049-7
|
| 40 |
Abdulrahman Alduraywish, Mostafa Ragheb, Ibrahim Taher, Nageh Louis, Khaled Aldossari, Rania Kishk. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study. Scandinavian Journal of Gastroenterology 2020; 55(8) doi: 10.1080/00365521.2020.1790649
|
| 41 |
Mohammad-Navid Bastani, Farah Bokharaei-Salim, Hossein Keyvani, Maryam Esghaei, Seyed Hamidreza Monavari, Mojtaba Ebrahimi, Saba Garshasebi, Shahin Fakhim. Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major. Archives of Virology 2016; 161(7) doi: 10.1007/s00705-016-2862-3
|
| 42 |
P. Kiely, C. Styles. Anti‐HCV immunoblot indeterminate results in blood donors: non‐specific reactivity or past exposure to HCV?. Vox Sanguinis 2017; 112(6) doi: 10.1111/vox.12547
|
| 43 |
Yue-Cheng Yu, Yue Wang, Chang-Lun He, Mao-Rong Wang, Yu-Ming Wang. Management of hepatitis C virus infection in hemodialysis patients. World Journal of Hepatology 2014; 6(6): 419-425 doi: 10.4254/wjh.v6.i6.419
|
| 44 |
Mohammad Saeid Rezaee Zavareh, Seyed Moayed Alavian, Hamidreza Karimisari, Mostafa Shafiei, Seyed Yasser Saiedi Hosseini. Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis. Hepatitis Monthly 2014; 14(8) doi: 10.5812/hepatmon.16089
|
| 45 |
Bashar M. Attar, David Van Thiel. A New Twist to a Chronic HCV Infection: Occult Hepatitis C. Gastroenterology Research and Practice 2015; 2015 doi: 10.1155/2015/579147
|
| 46 |
|
| 47 |
Roya Kahyesh‐Esfandiary, Zohreh‐Azita Sadigh, Maryam Esghaei, Mohammad‐Navid Bastani, Tahereh Donyavi, Alireza Najafi, Atousa Fakhim, Farah Bokharaei‐Salim. Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta‐thalassemia major: Occult HCV infection. Journal of Medical Virology 2019; 91(1) doi: 10.1002/jmv.25279
|
| 48 |
Ramin Yaghobi, Mohammad Javad Kazemi, Bita Geramizadeh, Seyed Ali Malek Hosseini, Javad Moayedi. Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis. Experimental and Clinical Transplantation 2020; 18(2) doi: 10.6002/ect.2017.0332
|
| 49 |
Mohamed Darwish Ahmed Abd Alla, Mostafa Kamel El Awady, Reham M. Dawood, Mostafa Abdelaziz Elhawary, Shabaan Salah Al-Azhari, Al-Shazly Gaber Mohamed Galal. Hepatitis C virus serologic relapse after treatment with direct-acting antivirals is dependent on viral RNA levels in peripheral blood mononuclear cells and the grade of liver cirrhosis. Archives of Virology 2018; 163(10) doi: 10.1007/s00705-018-3922-7
|
| 50 |
Saba Garshasbi, Farah Bokharaei-Salim, Khadijeh Khanaliha, Seyed Jalal Kiani, Saeed Kalantari, Mahin Jamshidi Makiani, Arezoo Marjani, Farzaneh Dehghani-Dehej, Roghayeh Babaei, Mohsen Sadeghi, Mohammad Abbasi-Kolli. SARS-CoV-2 Infection in Iranian People Living with Human Immunodeficiency Virus-1 Infection. Jundishapur Journal of Microbiology 2022; 15(1) doi: 10.5812/jjm.121929
|
| 51 |
Yahia El Shazly, Khaled Hemida, Mona Rafik, Reham Al Swaff, Zainab A. Ali‐Eldin, Shaimaa GadAllah. Detection of occult hepatitis C virus among healthy spouses of patients with HCV infection. Journal of Medical Virology 2015; 87(3) doi: 10.1002/jmv.24074
|
| 52 |
Abeya A Lotfi, Asmaa E Mohamed, Nahela A Shalaby, Deena S Eissa, Ehab El-Dabaa, Ayman M Sallam, Mahmoud M Kamel, Hisham Abdelaziz, Amal M El-Afifi, Ahmed S Abdel-Moneim. Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders. International Journal of Immunopathology and Pharmacology 2020; 34 doi: 10.1177/2058738420961202
|
| 53 |
N. Mousa, W. Eldars, H. Eldegla, O. Fouda, Y. Gad, N. Abousamra, E. Elmasry, M. Arafa. Cytokine Profiles and Hepatic Injury in Occult Hepatitis C Versus Chronic Hepatitis C Virus Infection. International Journal of Immunopathology and Pharmacology 2014; 27(1) doi: 10.1177/039463201402700111
|
| 54 |
Bashar M Attar, David H Van Thiel. Hepatitis C virus: A time for decisions. Who should be treated and when?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 33-40 doi: 10.4292/wjgpt.v7.i1.33
|
| 55 |
Mohammad Saeid Rezaee-Zavareh, Reza Hadi, Hamidreza Karimi-Sari, Mohammad Hossein Khosravi, Reza Ajudani, Fardin Dolatimehr, Mahdi Ramezani-Binabaj, Seyyed Mohammad Miri, Seyed Moayed Alavian. Occult HCV Infection: The Current State of Knowledge. Iranian Red Crescent Medical Journal 2015; 17(11) doi: 10.5812/ircmj.34181
|
| 56 |
Mahmoud A. Khattab, Yehia Zakaria, Eslam Sadek, Aliaa S. Abd EL Fatah, Magdy Fouad, Muhammed Khattab, Hend M. Moness, Nashwa Mohamed Adel, Elham Ahmed. Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response. Clinical and Experimental Medicine 2022; doi: 10.1007/s10238-022-00791-7
|
| 57 |
A. Kuroishi, K. Yasui, H. Matsukura, Y. Tani, R. A. Furuta. Comparison of neutralization profiles for anti‐HCV reactive donor samples with or without detectable HCV RNA. Vox Sanguinis 2015; 109(4) doi: 10.1111/vox.12301
|
| 58 |
Justyna Kaźmierczak, Kamila Caraballo Cortes, Iwona Bukowska-Ośko, Marek Radkowski. Virus-Specific Cellular Response in Hepatitis C Virus Infection. Archivum Immunologiae et Therapiae Experimentalis 2016; 64(2) doi: 10.1007/s00005-015-0364-8
|
| 59 |
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in Iran. World Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
|
| 60 |
Amir Hossein Nafari, Ahmad Ayadi, Zahra Noormohamadi, Fatemeh Sakhaee, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms. Infection, Genetics and Evolution 2020; 79 doi: 10.1016/j.meegid.2019.104144
|
| 61 |
Silvia Garazzino, Carmelina Calitri, Antonella Versace, Alda Alfarano, Carlo Scolfaro, Chiara Bertaina, Simona Vatrano, Federica Mignone, Francesco Licciardi, Clara Gabiano, Pier-Angelo Tovo. Natural history of vertically acquired HCV infection and associated autoimmune phenomena. European Journal of Pediatrics 2014; 173(8) doi: 10.1007/s00431-014-2286-6
|